Monday, April 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Strategy’s $14.5 Billion Paper Loss: A High-Stakes Bet on Bitcoin’s Future

Jackson Burston by Jackson Burston
April 13, 2026
in Analysis, Bitcoin, Crypto Stocks, Insider Trading
0
Strategy Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Strategy Inc. is navigating a financial paradox. The company, which holds more Bitcoin than any other publicly traded entity, reported a staggering $14.46 billion unrealized loss on its digital assets for the first quarter of 2026. This paper loss, driven by a 20% decline in Bitcoin’s price that pushed its value below the average purchase price of $75,694 per coin, has not slowed its aggressive accumulation strategy. In a bold move, the firm is shifting its financing approach to fuel further purchases while its own executives quietly reduce their equity stakes.

The company’s relentless buying continued into April, with an acquisition of 4,871 Bitcoin for approximately $330 million in just the first week. This brought its total hoard to 766,970 BTC, a position that now represents over 90% of its total assets. To finance this ongoing spree without excessively diluting common shareholders, Strategy is increasingly turning to “Stretch” preferred stock. For April 2026, it declared a monthly cash dividend of about $0.96 per share for this special series, aiming to attract capital with a variable dividend yield of 11.25%. The company still has roughly $37 billion in capacity across its various financing programs.

This financial engineering occurs against a backdrop of significant stock price pressure. Shares closed at €109.30 on Friday, marking an 18.55% decline since the start of the year. The stock now trades more than 70% below its 52-week high of €391.80 from last summer. Analyst sentiment reflects this caution. TD Cowen recently slashed its price target on Strategy from $440 to $350, citing a lower assumed Bitcoin price path and a reduced valuation multiple on projected Bitcoin gains. Analysts Lance Vitanza and Jonathan Navarrete maintained their Buy rating but now base their model on Bitcoin reaching $140,000 by December 2026, with Strategy purchasing about $5 billion in BTC quarterly.

Should investors sell immediately? Or is it worth buying Strategy?

Insider activity adds another layer of skepticism. Director Jarrod M. Patten sold 2,100 Class A shares in early April at prices between $123 and $131. This is part of a broader 18-month trend where insiders have been net sellers of 542,268 shares, with purchases of only 5,000 shares dwarfed by sales of 547,268.

Despite the massive paper loss and insider sales, Strategy’s commitment appears unshaken. The company’s remaining at-the-market (ATM) offering capacity across all share classes totals over $57 billion. According to models from BitcoinTreasuries.net, if Strategy deploys around $2.3 billion monthly with Bitcoin near $75,000, it could cross the threshold of holding one million BTC by November 2026. The stock currently trades at a multiple of 1.10 times its net asset value (mNAV), meaning the market still assigns a premium to the value of its Bitcoin holdings. Whether this premium holds depends on sustained demand for its various equity offerings amid volatility and, ultimately, on the future trajectory of the Bitcoin price that underpins the entire investment thesis.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from April 13 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 13.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Jackson Burston

Jackson Burston

Related Posts

Replimune Stock
Analysis

Replimune’s Lead Drug Hits Second FDA Wall, Triggering Survival Mode

April 13, 2026
Red Cat Stock
Analysis

Red Cat’s Defense Tech Ecosystem Nears Critical Junctions

April 13, 2026
Hims & Hers Stock
Analysis

Hims & Hers: A Strategic Overhaul Tested by Margins and Market Sentiment

April 13, 2026
Next Post
Plug Power Stock

Plug Power's Industrial Pivot Gains Validation from Science and Strategy

Hims & Hers Stock

Hims & Hers: A Strategic Overhaul Tested by Margins and Market Sentiment

Eutelsat Stock

Eutelsat's Launchpad: Balancing Explosive LEO Growth with Rocket Reliance

Recommended

German American Stock

German American Bancorp Shares Show Bullish Momentum

8 months ago
Berry Global Stock

Berry Global Shareholders Transition to Amcor Following Strategic Merger

5 months ago
Delta Air Lines Stock

Delta Air Lines Navigates Strong Earnings and European Labor Turbulence

7 months ago
Hbt Financial Stock

HBT Financial: A Regional Banking Powerhouse With Impressive Dividend Discipline

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hims & Hers: A Strategic Overhaul Tested by Margins and Market Sentiment

Plug Power’s Industrial Pivot Gains Validation from Science and Strategy

Strategy’s $14.5 Billion Paper Loss: A High-Stakes Bet on Bitcoin’s Future

Lufthansa’s Labor Gambit: A Strike Grounds Flights as a New Airline Takes Shape

TSMC’s 2nm Dominance Fuels Record Rally Ahead of Earnings

Refined Energy’s Uranium Hunt Awaits Lab Verdict as Warrant Lock-Up Expires

Trending

Replimune Stock
Analysis

Replimune’s Lead Drug Hits Second FDA Wall, Triggering Survival Mode

by SiterGedge
April 13, 2026
0

The U.S. Food and Drug Administration has delivered a potentially fatal blow to Replimune Group Inc., issuing...

Red Cat Stock

Red Cat’s Defense Tech Ecosystem Nears Critical Junctions

April 13, 2026
Eutelsat Stock

Eutelsat’s Launchpad: Balancing Explosive LEO Growth with Rocket Reliance

April 13, 2026
Hims & Hers Stock

Hims & Hers: A Strategic Overhaul Tested by Margins and Market Sentiment

April 13, 2026
Plug Power Stock

Plug Power’s Industrial Pivot Gains Validation from Science and Strategy

April 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Replimune’s Lead Drug Hits Second FDA Wall, Triggering Survival Mode
  • Red Cat’s Defense Tech Ecosystem Nears Critical Junctions
  • Eutelsat’s Launchpad: Balancing Explosive LEO Growth with Rocket Reliance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com